Halovate Cream (Halobetasol Cream)0.05%


Each Halovate Cream contains .05% Halobetasol is a steroidal medication to treat redness, itching, swelling, and irritation associated with skin conditions

ATC ClassificationD07AC21
Active IngrediantHalobetasol
Generic NameHalovate Cream
Dosage TypeCream
Packaging TypeTube in Box
Contains1 CREAM


Halobetasol Information


hal oh BAY ta sol


What is this drug used for?

• It is used to treat skin irritation.

• It is used to treat skin rashes.

• It is used to treat plaque psoriasis.

Frequently reported side effects of this drug

• Dry skin

• Burning

• Itching

• Stinging

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• High blood sugar like confusion, fatigue, increased thirst, increased hunger, passing a lot of urine, flushing, fast breathing, or breath that smells like fruit

• Cushing syndrome like weight gain in upper back or abdomen; moon face; severe headache; or slow healing

• Adrenal gland problems like severe nausea, vomiting, severe dizziness, passing out, muscle weakness, severe fatigue, mood changes, lack of appetite, or weight loss

• Skin changes like acne, stretch marks, slow healing, or hair growth

• Skin thinning

• Vision changes

• Severe skin irritation

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.


Medication Safety Issues

Sound-alike/look-alike issues:

Ultravate may be confused with Cutivate


Storage and Stability

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C and 30°C (59°F to 86°F). Do not freeze.

Foam: Do not refrigerate. Do not expose container to heat and/or store at >49°C (>120°F). Contents are under pressure; do not puncture or incinerate.


Adverse Reactions

Central nervous system: Headache, paresthesia

Dermatologic: Acne vulgaris, leukoderma, local dryness of skin, miliaria, pustules, secondary skin infection, stinging of the skin, telangiectasia, urticaria

Endocrine & metabolic: HPA-axis suppression, hyperglycemia

Local: Application site atrophy, application site burning, application-site dermatitis, application site erythema, application site pain, application-site pruritus, application site rash, application site vesicles

Respiratory: Upper respiratory tract infection

Rare, postmarketing, and/or case reports: Herpes zoster infection, increased blood pressure, influenza, local skin discoloration, nasopharyngitis, otitis media, pharyngitis, skin atrophy, wound

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , ,


Dosage Type

Packaging Type


There are no reviews yet.

Be the first to review “Halovate Cream (Halobetasol Cream)0.05%”

Your email address will not be published.